Radiopharm Theranostics Ltd ADR (RADX) Stock Price, Quote & News

Company Profile

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; a...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9824 5254

Fax: 61 3 9822 7735

Website: www.radiopharmtheranostics.com

Address:

62 Lygon Street, Level 3, Carlton, Australia

Ontherag Sep. 12 at 2:33 PM

$RADX so how much did we raise through the SPP?

1 · Reply

HappE Sep. 12 at 9:58 AM

$RADX Seen lotta radx pumpers on lnth. Buying on a biotech that has zero proven drugs or income is full slot machine. Dont buyin to the conspiracy--know that management will keep drawing, and until approval you are at whims of Wall street biotech pump, draw, dump.

0 · Reply

RadioIsotope25 Sep. 12 at 6:22 AM

Radiopharma hot Lilly partners with Aktis, deepening radiopharma investment | BioPharma Dive $CATX $RADX https://www.biopharmadive.com/news/aktis-eli-lilly-radiopharmaceuticals-cancer-deal/716700/

1 · Reply

Ontherag Sep. 11 at 8:45 PM

$RADX Company sucks, will exit on the next massive pop just like they do

1 · Reply

Uptowncheesecake Sep. 11 at 8:04 PM

$RADX guess I ride this shit to zero at this point?

1 · Reply

Lalalilala Sep. 11 at 7:59 PM

$RADX A 52-week low, less than a month before Phase 3 and the day after all the resolutions were voted on following the extraordinary general meeting of shareholders. Go figure? I'm down 50% tonight, it's very painful, and I curse Hopper and the entire management of this company. But the payoff is due at the end of the dance, and for now, the dance is far from over. Have a good weekend. I'm going on a week's holiday to Albania next week. It'll do me good (and you too, since I won't be posting) 😉 I hope to see Radioisotope25 send us a little message from time to time. 😏

1 · Reply

Lalalilala Sep. 11 at 3:43 AM

$RADX 100% résolutions approuved. What this morning's document says All resolutions were adopted: Shareholders approved all resolutions submitted to the vote by a majority vote. Financing approved: Tranche 2 of the institutional private placement, the creation of the associated options/warrants package, and the issuance of shares under the SPP were formally approved and sealed by the votes. Why is the share price dropping to AUD $0.08 this morning on the ASX? Seeing the share price fall by more than 10% today to reach AUD $0.008/$0.009 is a mechanical arbitrage reaction linked to the final issue price of the SPP.

0 · Reply

Lalalilala Sep. 10 at 2:05 PM

$RADX It's so rare that it definitely deserves a little photo 🥴🥴🥴

1 · Reply

akamal89 Sep. 10 at 11:56 AM

$RADX yo This is reading 1.78 premarket on google.

1 · Reply

Lalalilala Sep. 10 at 7:00 AM

$RADX

0 · Reply

Radiopharm Theranostics Reports Positive Phase 1 Imaging Data For RAD 301 In Pancreatic Cancer

2026-09-09T11:16:01.000Z - 4 days ago

Radiopharm announces data from imaging trial of RAD 301

Wed, 09 Sep 2026 07:00:00 -0400 - 4 days ago

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

2026-08-26T11:41:02.000Z - 18 days ago

Radiopharm Doses First Patient In Second Cohort Of Phase 1/2a RV-01 Trial

2026-08-26T11:15:09.000Z - 18 days ago

Radiopharm doses first patient in second cohort of RV-01 trial

Aug 26, 2026, 7:00 AM EDT - 18 days ago

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

RADX

2026-08-20T11:55:55.000Z - 24 days ago

Radiopharm Advances RAD202 Phase 1 Trial To Higher 180mCi Dose Level

Aug 20, 2026, 7:00 AM EDT - 24 days ago

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial

RADX

2026-08-17T13:24:53.000Z - 27 days ago

Radiopharm Theranostics To Meet FDA On Phase 3 Design For RAD101; Phase 2b Shows 93% MRI Concordance

2026-08-17T11:40:35.000Z - 27 days ago

Radiopharm schedules End-of-Phase 2 meeting with FDA for RAD101

2026-07-24T11:30:24.000Z - 7 weeks ago

Radiopharm announces $4.1M registered direct offering

Jul 24, 2026, 7:15 AM EDT - 7 weeks ago

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

RADX

Jul 22, 2026, 7:05 AM EDT - 7 weeks ago

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

RADX

Jul 22, 2026, 7:00 AM EDT - 7 weeks ago

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

RADX

2026-07-22T00:00:11.000Z - 7 weeks ago

Radiopharm Theranostics trading halted, news pending

2026-06-04T10:10:20.000Z - 3 months ago

Radiopharm initiated with a Buy at H.C. Wainwright

Apr 28, 2026, 12:00 PM EDT - 4 months ago

Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference

Apr 28, 2026, 12:00 PM EDT - 4 months ago

Radiopharm Theranostics Slides: Deutsche Bank ADR Virtual Investor Conference

Apr 23, 2026, 7:00 AM EDT - 4 months ago

Radiopharm Theranostics Reports Business Update

RADX

Apr 22, 2026, 6:00 PM EDT - 4 months ago

Radiopharm Theranostics Earnings release: Q3 2026

2026-04-20T12:08:59.000Z - 4 months ago

Radiopharm announces new data from Phase 0/1 HEAT trial

2026-04-08T11:45:06.000Z - 5 months ago

Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose

Apr 7, 2026, 7:00 AM EDT - 5 months ago

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

RADX

2026-03-27T15:36:04.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

SMMT SPRB

Mar 27, 2026, 7:00 AM EDT - 5 months ago

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

RADX

2026-03-26T15:41:23.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

Mar 24, 2026, 6:00 PM EDT - 5 months ago

Radiopharm Theranostics Transcript: Study result

Mar 24, 2026, 6:00 PM EDT - 5 months ago

Radiopharm Theranostics Press release: Study result

Mar 24, 2026, 5:30 PM EDT - 5 months ago

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

2026-02-24T12:54:28.000Z - 6 months ago

Radiopharm doses first patient in Phase 1/2a study of BetaBart

Jan 28, 2026, 7:00 AM EST - 7 months ago

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RADX

Jan 27, 2026, 6:00 PM EST - 7 months ago

Radiopharm Theranostics Earnings release: Q2 2026

Jan 21, 2026, 9:05 AM EST - 7 months ago

Radiopharm Theranostics Transcript: Emerging Growth Conference 89

2026-01-12T12:41:55.000Z - 8 months ago

Radiopharm increases ownership in Radiopharm Ventures to 87.5%

Jan 12, 2026, 7:00 AM EST - 8 months ago

RAD Increases Ownership in Radiopharm Ventures to 87.5%

RADX

2025-12-17T16:40:22.000Z - 9 months ago

Biotech Alert: Searches spiking for these stocks today

AIM

2025-12-17T13:50:36.000Z - 9 months ago

Radiopharm price target raised to $15 from $12 at Maxim

Dec 17, 2025, 7:00 AM EST - 9 months ago

Radiopharm Theranostics Registration statement: Registration filing

2025-12-16T17:10:30.000Z - 9 months ago

Biotech Alert: Searches spiking for these stocks today

2025-12-16T13:00:34.000Z - 9 months ago

Radiopharm price target raised to $16 from $13 at B. Riley

Dec 16, 2025, 7:00 AM EST - 9 months ago

Radiopharm Theranostics Registration statement: Registration filing

Dec 15, 2025, 6:00 PM EST - 9 months ago

Radiopharm Theranostics Transcript: Study Update

Dec 15, 2025, 6:00 PM EST - 9 months ago

Radiopharm Theranostics Press release: Study Update

2025-12-15T12:34:24.000Z - 9 months ago

Why Is Radiopharm Theranostics Stock (RADX) Up Today?

2025-12-15T12:05:27.000Z - 9 months ago

Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial

Dec 15, 2025, 7:00 AM EST - 9 months ago

Radiopharm Theranostics Achieves Primary Endpoint in 92% of Patients at Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

RADX

2025-11-26T14:20:48.000Z - 9 months ago

Radiopharm price target lowered to $13 from $15 at B. Riley

Nov 19, 2025, 6:00 PM EST - 9 months ago

Radiopharm Theranostics Slides: FY 2025

Nov 4, 2025, 12:30 PM EST - 10 months ago

Radiopharm Theranostics Transcript: Deutsche Bank ADR Virtual Investor Conference 2025

Oct 27, 2025, 7:00 PM EDT - 10 months ago

Radiopharm Theranostics Earnings release: Q1 2026

Oct 20, 2025, 7:30 AM EDT - 10 months ago

Radiopharm Theranostics completes A$35 million Placement and launches a A$5 million Share Purchase Plan

RADX

Oct 19, 2025, 6:00 PM EDT - 10 months ago

Radiopharm Theranostics Slides: Investor Presentation

Sep 24, 2025, 8:30 PM EDT - 11 months ago

Radiopharm Theranostics Transcript: KOL Event

Sep 1, 2025, 8:30 PM EDT - 1 year ago

Radiopharm Theranostics Transcript: KOL Event

Aug 26, 2025, 8:30 PM EDT - 1 year ago

Radiopharm Theranostics Transcript: KOL Event

Aug 26, 2025, 8:30 PM EDT - 1 year ago

Radiopharm Theranostics Press release: KOL Event

Tue, 29 Jul 2025 07:30:00 -0400 - 1 year ago

Radiopharm Theranostics reports Fiscal Year 2025 Financial Results and Business Update

Jul 28, 2025, 6:00 PM EDT - 1 year ago

Radiopharm Theranostics Annual report: Q4 2025

Jul 28, 2025, 6:00 PM EDT - 1 year ago

Radiopharm Theranostics Earnings release: Q4 2025

Tue, 22 Jul 2025 08:00:00 -0400 - 1 year ago

Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

Mon, 02 Jun 2025 08:00:00 -0400 - 1 year ago

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Mon, 19 May 2025 08:00:00 -0400 - 1 year ago

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

Apr 28, 2025, 6:00 PM EDT - 1 year ago

Radiopharm Theranostics Earnings release: Q3 2025

Mar 18, 2025, 6:40 PM EDT - 1 year ago

Radiopharm Theranostics Transcript: NWR Virtual Healthcare Conference

Mar 4, 2025, 9:10 AM EST - 1 year ago

Radiopharm Theranostics Transcript: TD Cowen 45th Annual Healthcare Conference

Jan 29, 2025, 6:00 PM EST - 1 year ago

Radiopharm Theranostics Earnings release: Q2 2025

Mon, 30 Dec 2024 08:00:00 -0500 - 1 year ago

Radiopharm Announces Strategic Co-Development Partnership with Lantheus for Australia

Fri, 20 Dec 2024 08:00:00 -0500 - 1 year ago

RAD 202 Receives Approval to Start Phase 1 Therapeutic Trial

Dec 5, 2024, 7:00 AM EST - 1 year ago

Radiopharm Theranostics Registration statement: Registration filing

Oct 29, 2024, 7:00 AM EDT - 1 year ago

Radiopharm Theranostics Earnings release: Q1 2025

Sep 30, 2024, 3:30 AM EDT - 1 year ago

Radiopharm Theranostics Annual report: H2 2024

Thu, 19 Sep 2024 12:00:00 -0400 - 1 year ago

Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited

Ontherag Sep. 12 at 2:33 PM

$RADX so how much did we raise through the SPP?

1 · Reply

HappE Sep. 12 at 9:58 AM

0 · Reply

RadioIsotope25 Sep. 12 at 6:22 AM

Radiopharma hot Lilly partners with Aktis, deepening radiopharma investment | BioPharma Dive $CATX $RADX https://www.biopharmadive.com/news/aktis-eli-lilly-radiopharmaceuticals-cancer-deal/716700/

1 · Reply

Ontherag Sep. 11 at 8:45 PM

$RADX Company sucks, will exit on the next massive pop just like they do

1 · Reply

Uptowncheesecake Sep. 11 at 8:04 PM

$RADX guess I ride this shit to zero at this point?

1 · Reply

Lalalilala Sep. 11 at 7:59 PM

1 · Reply

Lalalilala Sep. 11 at 3:43 AM

0 · Reply

Lalalilala Sep. 10 at 2:05 PM

$RADX It's so rare that it definitely deserves a little photo 🥴🥴🥴

1 · Reply

akamal89 Sep. 10 at 11:56 AM

$RADX yo This is reading 1.78 premarket on google.

1 · Reply

Lalalilala Sep. 10 at 7:00 AM

$RADX

0 · Reply

Lalalilala Sep. 9 at 8:02 PM

$RADX Those little bitches managed to make us close in the red when we were in the green for 95% of the session! And at our lowest point with 139 shares 🤮🤮🤮🤮🤮 The trend will reverse soon. No problem for me.

0 · Reply

Lalalilala Sep. 9 at 6:27 PM

$RADX Perhaps the end of the downward ordeal and dilution!? The indicators, even if they are not super reliable with this volume and current dilution, still show us a small glimmer of hope: we must believe it.

0 · Reply

Hegemon Sep. 9 at 6:23 PM

$RADX I dont get why its not moving more than that...

1 · Reply

Lalalilala Sep. 9 at 3:27 PM

$RADX

0 · Reply

Lalalilala Sep. 9 at 2:40 PM

$RADX 💰

0 · Reply

Manpreet00 Sep. 9 at 6:04 AM

$RADX didn’t move at all in Australia on the RAD301 news lol

0 · Reply

twitofstock Sep. 9 at 4:55 AM

$RADX Just on imaging pipeline we should be valued a lot more.

0 · Reply

twitofstock Sep. 9 at 4:47 AM

$RADX "Radiopharm Theranostics Announces Positive Data from the Phase1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma" - so now we have a positive phase1 in rad301 and a positive on phase2b on rad101

0 · Reply

twitofstock Sep. 8 at 11:17 AM

$RADX I just don't understand the management of this company 1. Why increase the vol. of spp from $6 mil to 10mill if the last one failed and the price is down the drain? 2. Why schedule an meeting with FDA on 1st Oct if they dont have full specificity and sensitivity data? Which will be the primary endpoints in phase3. 3. Why no announcements about conference participation to present new data abou rad101, rad202, rad204. All conferences where I searched is full of participants, Lantheus, Curium, Aktis etc. But our dear turd is absent on all of them. 🤔

2 · Reply

Lalalilala Sep. 8 at 6:35 AM

$RADX

0 · Reply

Manpreet00 Sep. 8 at 12:14 AM

$RADX transfer of stock ownership from retail to long term institutional holders before a major value inflection point is very common. Most will sell at break even now. It’s a common trick used to psychologically manipulate retail to dump their shares.

0 · Reply

biospeculator Sep. 7 at 5:13 PM

$RADX One last swap/trade idea for those still long RADX and then I will be moving along. Please do your own due diligence however. TENX. I sold at $14-$15 as per my previous posts. However now below $2 I am a buyer. The drug works despite the recent phase III failure imo. I simply believe they designed the trial wrong. Major institutions have been buying for this simple reason. Some are the smartest biotech investors in the market. The company is going back to the FDA for guidance. GLTA

1 · Reply

Market Cap	N/A
Revenue (ttm)	N/A
Net Income (ttm)	N/A
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	10,245
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A